Are you at risk for Type 2 diabetes?

For example, if you are overweight or have a family history of the disease you could be at risk.
Diabetes prevention is as basic as eating more healthfully, becoming more physically active and losing a few extra pounds. Making a few simple changes in your lifestyle now may help you avoid the serious health complications of diabetes later, such as nerve, kidney and heart damage.
Changing your lifestyle could be a big step toward diabetes prevention — and it’s never too late to start.

Read more

The cost to care for diabetics in the United States has increased dramatically over the last five years, but a study conducted by researchers at Wake Forest University may have identified a method to help diabetics better control their health.

The American Diabetes Association estimates that care for diabetics, including diabetes supplies, hospitalizations, medications and other associated expenses cost $245 billion in 2012. The ADA last estimated the total annual costs for diabetics in 2007. At that time, the total cost of diabetes was estimated at $174 billion.

Read more

Do you have a history of type 1 diabetes in your family? Are you currently expecting a baby as well? If so, you may want to take a look at the last few issues of the Journal of the American Medical Association’s respected periodical, JAMA Pediatrics.

Read more

According to the CDC’s research, diabetes is one of the top five leading causes of death among America’s Latino population. The majority of those that find themselves in that high risk category tend to have type 2 diabetes. Because of that, some members of the scientific research community have long believed that the disease’s prevalence in the Latino community is connected to genetics. So they’ve been conducting research over the last few years to either prove or disprove their assumptions. On December 25, 2013, one of those research groups published their latest findings in Nature magazine.

Read more

Diabetics living in the Golden State may want to take notice of a debate currently taking place among their legislators. That’s because the heated conversation has to do with a bill regarding lancing devices, insulin needles and other similar diabetes testing supplies. If the bill does eventually turn into law, it could change how diabetes testing supplies will need to be sold, purchased and disposed of within the state. Here’s more:

Read more

A study related to gestational diabetes appeared in The Endocrine Society’s publication, the Journal of Clinical Endocrinology and Metabolism. It was titled Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline. Upon its release, obstetricians undoubtedly started to question how they’ve been treating diabetic and pre-diabetic pregnant women for years.

The study was actually designed to come up with best practices that physicians could use to treat diabetic women of child bearing age. It looked at pregnant women with a pre-existing type 1 or type 2 diabetes diagnosis as well as those who developed gestational diabetes.

Read more

The Royal College of Surgeons in Ireland released an interesting piece of news. It was done in conjunction with the University College Cork’s Sociology Department and focused on recent type 1 diabetes research. According to the Ireland based healthcare professionals’ research, there are several factors that cause young people afflicted with type 1 diabetes to become stressed. They also found that those factors may be mitigated by providing type 1 diabetes sufferers with access to clinical and social support as well as educational materials.

Read more

According to the International Diabetes Foundation’s figures, more than 380 million people around the world are coping with a diabetes diagnosis. That’s a lot of people that must alter their way of living and use type 1 diabetes testing supplies. However, if the researchers at the Harvard School of Public Health are correct, that number may drop in the future.

 

In December 2013, researchers connected with the school’s Hotamisligil Laboratory released the results of a study that revealed a potential way to prevent the disease from occurring. The potential solution to the longstanding disease rests with our endoplasmic reticulum (ER). For those that are unfamiliar with ER, it is an organelle found in some human cells. There are two types. They are referred to as rough and smooth. The rough one aids in protein synthesis. In those with type 1 diabetes, those cells are not functioning properly.

What researchers discovered is that there is an ambiphilic bile acid that has the capability of offsetting that dysfunction in laboratory mice. As a result of that offsetting, the onset of type 1 diabetes may effectively be delayed or stopped altogether. Of course additional research and type 1 diabetes testing must be conducted in the coming years to determine whether or not the same results may be possible to obtain in humans.

Until then, those living with the disease must continue with their type 1 diabetes testing regimens and insulin injections to ensure their quality of life. At this time, failure to properly manage the disease often results in the development of assorted comorbidities. Those comorbidities include vision loss, kidney failure, strokes, heart attacks and blood vessel disease.

If you are one of the many Americans faced with having to use diabetes lancets, you may be excited to learn that there could very well be alternatives available in the near future. Word of the potential alternative was released during the last World Diabetes Congress. Here’s a look at what the advancement is and how it may change diabetics’ lives:

The company making the announcement was Abbott Diabetes Care. The potential advancement is being touted as an ambulatory glucose profile device. It is currently undergoing a clinical trial period. So it is likely to remain unavailable until sometime in the future. Nonetheless, the results thus far have been encouraging.

Read more

Earlier this year, the U.S. Federal Drug Administration began ruminating over the idea of changing the way that blood glucose monitors are used and classified. Needless to say, it created quite a stir among members of the healthcare community. Many people supported portions of the non-binding guidelines and vehemently opposed others. So what’s all the controversy about?

Read more